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Abstract  The aims of this systematic review are to 
identify and analyse the scientist literature available 
evidence about the use of potentially inappropriate 
medications, according to the Beers Criteria, that is 
associated with mortality in the elderly people.It have been 
made a search of publications in most traditional electronic 
databases among the scientific community (Pubmed / 
Medline, EMBASE and Web of Science) and it have been 
selected publications that obey the criteria of 'observational 
study', 'elderly' and 'Beers Criteria' and that they had as a 
result the mortality of the study population. After 
publications selection it proceeded to dump data by two 
researchers independently to avoid selection bias. The 
methodological quality of the selected studies was assessed 
by the checklist Newcastle-Ottawa. The final sample of this 
systematic review has been made up of 17 studies published 
in Pubmed and Embase databases majority, 8 of which make 
up the meta-analysis. In descriptive synthesis has been 
observed that most of the studies have a level of evidence IV 
(94'1%) with cohort delineation (94'1%) and non-probability 
sampling technique (70'6%).Data collection was prospective 
in 58'8% of cases, with a sample (n) greater than 1000 
elderly (64'7%) and followed up for 6 to 12 months 
(52'9%).The meta-analysis involving 90.611 elders informed 
that users who take inappropriate drug according to the Beers 
Criteria had a higher relative risk for mortality outcome (RR 
= 1.11, 95% CI 1'01-1'22 P = 0'023), regardless of study 
stage, comorbidity presence, polypharmacy or type of 
inappropriate medication used. 
Keywords  Elderly, Inappropriate Medication, Mortality, 
Systematic Review, Meta-Analysis, Beers Criteria 
 
1. Introduction 
The current demographic changes, generally characterized 
by a dramatic improvement in life expectancy and resulting 
increase in population rates aging is, among other things, 
showing new health needs, among which include high 
frequency of comorbidities and using associated 
polypharmacy. The multiple disorders and their treatments 
can become triggers for adverse effects associated with 
potentially inappropriate prescribing drugs that often 
involves clinical complications and adverse effects on health 
and disease control. 
The use of polypharmacy in elderly, along with aging 
metabolic changes, has been generating some controversy 
and doubts about the suitability use of some drugs while on 
the impact of these drugs, potentially inappropriate, may 
have on mortality among elderly population. However, 
despite clinical suspicion, there seems no sufficient scientific 
evidence to claim that potentially inappropriate medication 
use (IMU) in the elderly is associated with mortality, so that 
posed a literature analysis to try to find these evidence. As a 
reference tool of inappropriate medications it has worked 
with the Beers criteria, which includes 41 drugs or classes of 
drugs considered inadequate to use with elderly in any 
situation and 7 considered unsuitable according to 
circumstances or doses, both groups also classified 
according to severity, high or low. 
2. Materials and Methods 
It conducted a systematic review of published studies in 
electronic databases that showed a positive relationship 
between inappropriate drug prescription in the elderly and 
mortality outcome, in order to identify and analyse evidence 
on the association of use potentially inappropriate drug in the 
elderly according Beers (IMU) and mortality. 
It have been used the Beers criteria because is the most 
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widely used internationally to assess the drug therapy 
adequacy in the elderly. 
It were included in the analysis all observational studies 
conducted with people over 65 years old (in developed 
countries) or 60 (in developing countries), regardless of the 
study context (hospital, outpatient or home) and that would 
make reference to the drugs misuse as the Beers criteria 
(1991, 1997 and 2003) resulting in death. 
It was established as the analysis period, studies published 
between 1991 (first publication year of Beers criteria) and 
2010. 
It were excluded from RS, the study sample of frail elderly, 
because it not determine whether this circumstance was 
significantly determined outcome of mortality, and also 
those that show intermediate results, such as RAMs, falls, 
hospitalizations or other, that somehow could have a 
decisive influence as a mortality cause. 
The databases searched were: Bank CAPES thesis, 
CINAHL, Current contents connect, Embase, International 
Lilacs, Pharmaceutical Abstracts, Proquest dissertation and 
Theses, Pubmed / Medline, Scopus, Web of Science and 
Science direct. 
The initial search provided a total of 1193 articles, their 
methodological rigor was analysed by Newcastle-Ottawa 
checklist.After removing duplicate articles or those 
considered with insufficient scientific rigor, it leaved a 
sample of 1042 items (n = 1042) they were analysed by title 
and abstract by two researchers independently.Each 
overturned different data items to a database consisting of 
following variables: number of study; publishing-related 
variables (database, type of publication, country, language, 
authors and area of operation), study purpose, 
method-related variables (study design, duration, data 
collection, sample type, stage version of the Beers criteria, 
outcome information source and age), characteristics of the 
sample (mean age, sex, level of comorbidities, chronic 
diseases number, diagnosis, activities assessment of daily 
living, cognitive assessment, number of drug or class of 
drugs used), IMU (incidence, number of people who took at 
least one IMU and its characteristics-gender, age, 
comorbidities, number of medications-) and results (number 
of people who died and made use of IMU, measure of effect, 
confidence intervals, p value and author's conclusion) and 
evidence level too. 
In 12 of the cases were sent an email to the study authors 
to complete the information specified.It expanded 
information in 3 cases, but the remaining 9, 3 authors had no 
more data and 6 did not respond. 
In meta-analysis conducting it adopted a random effects 
model inclusive for subgroup analysis because all studies 
had different characteristics:different ages of elderly and 
health conditions, evaluation of IMU by the Beers criteria in 
3 different versions and healthcare scenarios 
differentiated.These different characteristics collected in the 
analysed studies led to diversity and heterogeneity existence, 
so the random effect values the contribution of small studies 
giving results in a wider confidence interval. 
In this RS it’s considered the heterogeneity test. 
Synthesis measurement were taken effect relative risk and 
the required number of users-cases in which IMU used gave 
a mortality result (NNH) used to measure complement 
intervention impact of IMU use. 
To check the strength of the results of the meta-analysis 
was performed a subgroup analysis considering outcome 
studied (mortality), IMU evaluation by the Beers criteria 
2003 version; as a backdrop, the hospital (n = 8). 
The meta-analysis was performed with L.Bax MIX 2.0 
Professional software for meta-analysis in Excel version 
(2.01.0) Biostat XL 2010 program. 
By having an outcome so defined (mortality), it is use 
controlleddescriptors and keywords as specified search 
strategy seeking to obtain more relevant studies.However, in 
the preliminary phase, found no systematic review databases 
RS (Bandolier, Clinical Evidence, Cochrane Library and 
other).This study systematic review databases were located 
in Pubmed / Medline and EMBASE, mostly. 
Table No. 1 shows controlled and uncontrolled descriptors 
for each study used in search, according to PICO* strategy. 
Time limit was established as early 1991, because it was 
the year that Beers criteria arises.As a final limit it was 
established in 2010. 
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Table 1.  Controlled and uncontrolled descriptors used in the search, according to PICO strategy in this SR 
P MESH descriptor (Pubmed/Medline) Aged/ “aged, 80 and over” 
Uncontrolled descriptor centenarian (s) / nonagenarian (s) / octogenarian (s) / senior (s) / geriatric / elder (s) / older / old / ancient 
I MESH descriptor “inappropriate prescribing” 
Uncontrolled descriptor “inappropriate prescription (s)” / suboptimal prescribing” / “inappropriate medication (s)” / “inappropriate drug (s)” / 
“inappropriate medicine (s)” / “inadequate prescribing” / “inadequate prescription (s)” / “suboptimal prescription (s)” / 
“suboptimal therapy” / “inadequate medications” / “drug related problem (s)” / “medication-related problem (s)” / beers 
/ “beers criteria” / “beers list” 
O MESH descriptor Mortality / “mortality [subheading]” / “hospital mortality” / death 
/ “outcome assessment (health care)” 
Uncontrolled descriptor “adverse drug event (s) / “adverse event (s)” / outcome (s) / mortalities / deaths / “adverse medication events” 
P DECS descriptor (LILACS)* Idoso 
Uncontrolled descriptor / 
I DECS descriptor “Prescriçãoinadequada” / “uso de medicamento”/ 
“preparaçõesfarmacêuticas” 
Uncontrolled descriptor “medicamentopotencialmenteinapropriado” 
P EMTREE descriptor (EMBASE) Aged / “aged hospital patient” / “very elderly” / “geriatric patient” 
Uncontrolled descriptor centenarian (s) / nonagenarian (s) / octogenarian (s) / elder (s)/ older / old 
I EMTREE descriptor “inappropriate prescribing” / prescription / drug / “drug therapy” 
Uncontrolled descriptor “suboptimal prescribing” / “inappropriate medication (s)” / “inappropriate drug (s)” / “inappropriate medicine (s)” / 
“suboptimal prescription (s)” / “suboptimal medication” / 
“suboptimal drug” / “inadequate medication (s)” / “inadequate prescribing” / “inadequate prescription (s)” / 
“inadequate drug (s)” 
O EMTREE descriptor mortality / death / “adverse outcome” / “drug fatality” 
Uncontrolled descriptor “adverse drug event (s)” 
P CINAHL descriptor aged / “aged, 80 and over” / “aged hospitalized” 
Uncontrolled descriptor centenarian (s) / nonagenarian (s) / octogenarian (s) / senior (s)/ geriatric / elder (s) / older / old / ancient / elderly 
I CINAHL descriptor drugs / “prescribing patterns” / “drug therapy” / “prescription, drug” / drug utilization” 
Uncontrolled descriptor medication (s) / medicine (s) / prescribing / prescription (s) / inappropriate / inadequate / suboptimal 
O CINAHL descriptor mortality / “hospital mortality” / death / “outcome assessment” / “outcome (health care)” 
Uncontrolled descriptor outcome (s) / “adverse event (s)” / mortalities / deaths / “adverse drug event (s) / “adverse medication event (s)” 
*Lilacs: portuguesedatabase ;P:patient/population   I:intervention/indicator   C: comparison/control  O: outcome 
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3. Results 
The results are grouped by the following items: study selection process, publications characterization (general, 
methodological approach) sample characteristics, IMU description, elders groups who used or not IMU and the respective 
measures effect on the outcome, meta-analyses and subgroup analysesIMU classified by the Beers criteria (2003) and 
mortality in the hospital setting. 
Of the eleven electronic databases consulted in the first stage of study, most studies identifying occurred in Science Direct 
(n = 244, 20.5%) and Web of Science (n = 215, 18.0%). 
Of the studies reviewed holistically, the 27.5% were found in the Pubmed / Medline database (n = 25), the 24.2% in 
Embase (n = 23) and 23.4% in IPA (n = 15). 
Of the initially selected studies (n = 1193) were excluded 151 (12.7%) because they were duplicates and 1042 (87.3%) 
remaining 1002 were further excluded after reading the abstract, thus leaving 40 (3.8%) studies who underwent a 
comprehensive reading. 
Comprehensive reading revealed that 25 jobs (2.4%) were on non-relevant aspects to the review, which 15 (1.4%) were 
finally suitable for the sample, but when reviewing the references of these 15 studies, was decided to analyse and include two 
more articles in the final sample being selected a total of n = 17. 
The following Table 2 shows the articles general characteristics included in this SR: 
Regarding the methodological approach, we found that most of the studies had a level of evidence IV (n = 16; 94.1%) with 
cohortdelineation (n = 16; 94.1%), non-probability sampling technique (n = 12; 70.6%), data collected prospectively (n = 10, 
58.8%), larger sample of 1000 elderly (n = 11; 64.7%) with followingof 12-24 months (n = 9, 52.9%) and mortality results 
obtained by database query (n = 13; 76.5%). 
Regarding the characteristics of the sample, showed that the majority of studies involved mainly female individuals (n = 16; 
94.1%) with an average age greater than 70 years (n = 14, 82.4%) and using at least two drugs (n = 15; 88.2%). 
In 9 of the 17 studies (52.9%), the researchers described the number of comorbidities using the Charlson comorbidity index 
(n = 5; 29'4%). 
Others 9 (52'9%) also described the elderly functional assessment byscales Barthel, Katz and others. 
The mean number of drugs used in the elderly was higher in those studies examining medicines use in long-standing 
institutions (E11, E36, E94, E1421, and in Table 2) than in the hospital setting (E424, E618, E1219, E165, in Table 2) and this, 
more than in the community (E11, E22, E523, E108, E1313, E1511, in Table 2). 
C: community; LSI: long-standing institution, ND: data not described in the study 
In most studies (n = 12; 70.5%) IMU was classified as aninappropriate drug independently of diagnosis, therapy dose or 
time.In 23.5% of cases (E36, E618, E1114, E165) it’s given a more extended classification, taking into account the 
drug-pathology interaction condition.Of these four studies, only 2 reported the results. 
Table 2.  General characteristics of the publications included in the SR 
Studio Authors Title Journal/yea
r 
Publication 
language 
(country of 
publication) 
Knowledge 
area 
Database 
E011 Barnett K, 
McCowan C, 
Evans JMM, 
Gillespie ND, 
Davey PG, Fahey 
T 
Prevalence and outcomes of use 
of potentially inappropriate 
medicines in older people: 
Cohort study stratified by 
residence in nursing home or in 
the community 
BMJ 
Quality and 
Safety/ 
2011 
English (UK) Public 
Health 
Embase; 
Web of 
science; 
Pubmed; 
CINAHL 
E022 Beer C, Hyde Z, 
Almeida 
OP, Norman P, 
Hankey GJ, 
Yeap BB, Flicker 
L 
Quality use of medicines and 
health outcomes among a 
cohort of community dwelling 
older men: an observational 
study 
British 
Journal of 
Clinical 
Pharmacolo
gy/2011 
English 
(AUST) 
Medicine Pubmed 
E036 Dedhiya SD, 
Hancock E, 
Craig BA, 
Doebbeling CC, 
Thomas J 
Incident Use and Outcomes 
Associated With Potentially 
Inappropriate Medication Use 
in Older Adults 
The 
American 
Journal 
of Geriatric 
Pharmacoth
erapy/2010 
English (USA) Pharmacy Pubmed; 
Embase; 
Scopus; 
Web of 
Science 
E0425 Szlejf C Eventos adversos médicos em 
idosos hospitalizados:frequência 
e fatores de riscoemenfermaria 
de geriatria 
PhD 
thesis/2010 
Portuguese 
(BRA) 
Medicine CAPES 
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E0523 Pozzi C, Lapi F, 
Mazzaglia, G, 
Inzitari M, 
Boncinelli 
M,Geppetti P, 
MugelliA,Marchi
onni N, Bari M 
Is suboptimal prescribing arisk 
factor for poor healthoutcomes 
in community welling elders? 
The ICAReDicomano study 
Pharmacoe
pidemiolog
y 
and Drug 
Safety/201
0 
English 
(ITALY) 
Medicine Pubmed; 
Embase; 
Web of 
Science 
E0618 Mansur N, Weiss 
A, 
Beloosesy Y 
Is there an associationbetween 
inappropriateprescription drug 
use andadherence in 
dischargedelderly patients? 
The annals 
of 
Pharmacoth
erapy/2009 
English 
(ISRAEL) 
Medicine Pubmed; 
Embase; 
IPA; 
Scopus; 
Web of 
Science 
E0715 Lin H, Liao C-C, 
Cheng S-H, 
Wang P-W, 
Hsueh Y-S 
Association of potentially 
inappropriate medication use 
with adverse outcomes 
inambulatory elderly 
patientswith chronic diseases - 
Experience in a 
TaiwaneseMedical Setting 
Drugs 
Aging/2008 
English 
(TAIWAN) 
Pharmacy Pubmed; 
Scopus; 
Embase; 
IPA; Web 
of 
science; 
CINAHL; 
Current 
Contents 
Connect 
E0821 Page RL, Ruscin 
JM 
The risk of adverse drugevents 
and hospital-relatedmorbidity 
and mortality amongolder adults 
with potentiallyinappropriate 
medication use 
The 
American 
Journal 
of Geriatric 
Pharmacoth
erapy/2006 
English(USA) Pharmacy Science 
direct; 
Scopus; 
Pubmed 
E0924 Raivio MM, 
Laurila JV, 
Strandberg TE, 
Tilvis RS, 
Pitkälä KH 
Use of Inappropriate 
Medications 
and Their 
PrognosticSignificance Among 
In-Hospitaland Nursing Home 
Patients withand without 
Dementia in Finland 
Drugs 
Aging/2006 
English 
(FINLAND) 
Medicine Embase; 
Current 
Contents 
Connect; 
Web of 
Science; 
IPA; 
CINAHL 
E108 Espino DV, 
BazalduaOV,Pal
mer RF, Mouton 
CP,Parchman 
ML, Miles 
TP,Markides K. 
Suboptimal medication useand 
mortality in an oldercommunity 
based cohort:results from the 
Hispanic 
EPESE Study 
Journals of 
gerontol. 
Series 
A,Biologic
al sciences 
andmedical 
sciences/20
06 
English (USA) Medicine References 
E1114 Lau DT, Kasper 
JD, Potter 
DEB, Lyles A, 
Bennett RG 
Hospitalization and 
deathassociated with 
potentiallyinappropriate 
medicationprescriptions among 
elderlynursing home residents 
Arquives of 
Internal 
Medicine/2
005 
English (USA) Medicine Pubmed;W
ebofScienc
e;IPA; 
Embase;Cu
rrentConten
tsConnect;
Scopus 
E1219 Onder G, Landi 
F, Liperoti 
R, Fialova D, 
Gambassi G, 
Bernabei R 
Impact of inappropriate druguse 
among hospitalized olderadults 
European 
Journal of 
Clinical 
Pharmacolo
gy/2005 
English 
(ITALY) 
Medicine Pubmed;W
ebofScienc
e;CurrentC
ontentsCon
nect;Scopu
s 
E1313 Klarin I, Wimo 
A, Fastbom J 
The association ofinappropriate 
drug use withhospitalisation and 
mortality - 
A population-based study ofthe 
very old 
Drugs 
Aging/2005 
English (USA) Public 
Health 
Pubmed; 
Scopus; 
Embase; 
IPA; Web 
of 
science; 
CINAHL; 
Current 
Contents 
Connect 
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E1421 Perri III M, 
Menon 
AM,Deshpande 
AD, 
ShindeSB,Jiang 
R, Cooper JW, 
CookCL, Griffin 
SC, Lorys RA 
Adverse outcomes 
associatedwith inappropriate 
drug use innursing homes 
The Annals 
of 
Pharmacoth
erapy/2005 
English (USA) Pharmacy Pubmed; 
Embase; 
Web of 
Science; 
IPA; 
Scopus 
E1511 Hanlon JT, 
FillenbaumGG,K
uchibhatla M, 
ArtzMB,Boult C, 
Gross CR, 
Garrard 
J. ,Schmader KE 
Impact of inappropriate druguse 
on mortality and functionalstatus 
in representativecommunity 
dwelling elders 
Medical 
care/2002 
English (USA) Pharmacy Scopus; 
Web of 
Science; 
CINAHL; 
Pubmed 
E165 Chin MH, Wang 
LC, Jin 
L,Mulliken R, 
Walter J, 
HayleyDC, 
Karrison TG, 
Nerney 
MP, Miller A, 
Friedmann PD 
Appropriateness of medication 
selection for older persons inan 
urban academicemergency 
department 
Academic 
Emergency 
Medicine/1
999 
English (USA) Medicine Pubmed; 
Embase; 
Web of 
Science; 
Scopus 
E1710 Gupta S, 
Rappaport HM, 
Bennett LT 
Inappropriate DrugPrescribing 
and RelatedOutcomes for 
Elderly 
Medicaid BeneficiariesResiding 
in Nursing Homes 
Clinical 
Therapeutic
s/1996 
English (USA) Pharmacy References 
Table 3.  Features based on the sample of seniors in the studies included in the SR. 
Studio Sex Age 
(mean in 
years) 
Diagnosis number of 
chronic 
diseases(
mean)/ 
scale of 
comorbidi
ties 
(mean) 
functional evaluation cognitive 
evaluatio
n 
number of drugs 
/ class of drugs 
used mean 
E11 C: 
57’0% 
female 
LSI: 
72’3% 
female 
66 to 99 
(C: 75’2 
LSI: 
84’5) 
ND ND ND ND C: mean - 8,8 
classes / elderly 
LSI: 11’6 mean 
class / elderly 
E22 100% 
male 
65 to 83 
(77) 
ND Charlson 
1-2 points 
(19’2%) 
ND ND ≥5 
drugs: 35’8% 
elderly 
 
E36 76’5% 
female 
≥ 65 
(83’1) 
ND Charlson: 
2’25 
ND ND 1 to 10: 24’3% 
elderly 
11 to 15: 28’3% 
elderly 
16 to 20: 23’4% 
elderly 
+20: 24’0% 
elderly 
E425 59’1% 
female 
≥ 60 
(78’1) 
Depression (18’7%) 
Dementia (29’8%) 
Delirium (35’7%) 
Infection (55’6%) 
Charlson: 
3’07 
Katz index independent 
Mean:4’13 
ND Mean: 5’73 
drugs 
E523 57’1% 
female 
≥ 65 
(73±6’8) 
ND 2’3 
diseases 
Disability in basic 
activity = 7’5% 
Disability in 
instrumental activity = 
32% 
ND Mean: 2’2 
drugs/elderly 
≥5drugs: 12’3% 
E618 61’8% ≥ 65 Neurological (18%) 6’3 Katz index Mini-me 5'9 at discharge 
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female (81’1) Orthopaedic (18%) 
Fall and imbalance 
(15%) 
Hemato-oncology 
(11%) 
diseases Independent (58%) 
Partial (27’4%) 
Total (14’6%) 
ntal: 
Normal 
(78’8%) 
Mild to 
moderate 
(12’7%) 
Severe 
(8’5%) 
6'5 after a month 
of discharge 
E715 55’5% 
female 
≥ 65 
(74’7) 
Hypertension 
(24’2%) 
Heart disease 
(14’1%) 
Diabetes mellitus 
(11’5%) 
1 disease 
(27’8%) 
2 diseases 
(46%) 
3 diseases 
(21’2%) 
≥ 4 
diseases 
(5%) 
ND ND ≤4 drugs 
(80’8%) 
 
E821 68’9% 
female 
≥75 
(79) 
ND ND ND ND ND 
E924 82’0% 
female 
≥ 70 
(86) 
ND CharlsonS
cale 
Dementia 
:> 2 points 
(42'4%) 
Without 
dementia: 
> 2 points 
(30'6%) 
Clinical Dementia 
Rating scale 
Dependence among 
elderly with dementia: 
76'9% 
Dependence among 
older adults without 
dementia: 21'2% 
Mini-me
ntal 
Dementia 
9’9 
points 
(mean) 
Mean: 9’0 drugs 
E108 64’5% 
female 
65 to 99 
(73) 
Cardiovascular 
disease (12'5%) 
Neoplasia (6'3%) 
Diabetes mellitus 
(32'9%) 
Hypertension 
(56'9%) 
ND Older American 
Resource 
Scale 
Disability in basic 
activity = 14’5% 
Disability in 
instrumental activity = 
41'5% 
ND >4 
Drugs=21’1% 
E1114 73’8% 
female 
≥ 65 Dementia (47’7%) ND 0-3 limitations (26’3%) 
4-5 limitations (30’3%) 
6 limitations (46’2%) 
ND ND 
E1219 52’2% 
female 
≥ 65 
(78’8) 
Hypertension 
(37’8%) 
Ischemic heart 
disease (27’6%) 
Heart failure 
(21’5%) 
Diabetes (20’2%) 
Charlson 
≥2 points 
(47’8%) 
Disability in basic 
activity = 38’5% 
Cognitiv
e 
impairme
nt 
(34’6%) 
-≥5 
drugs: 74’3% 
E1313 57’9% 
female 
≥ 75 
(82’6) 
ND ND ND ND Mean: 4’4 drugs 
≥5 drugs: 40’1% 
E1421 81’6% 
female 
≥ 65 
(84’6) 
Dementia 
(70’5%) 
Heart disease 
(66’9%) 
Hypertension 
(57’1%) 
ND ND ND Mean: 8’7 drugs 
≥5 drugs: 76’5% 
E1511 64’8% 
female 
≥ 65 ND ND Katz Index, 
Older 
American Resource 
Scale and 
Rosow-Breslau Scale 
Disability in one or 
more basic activity: 
18’3% 
Disability in 
instrumental activity = 
35’5% 
Cognitiv
e 
impairme
nt 
(15’8%) 
2 to 4 drugs: 
42’9% 
 
 
E165 63’0% 
female 
≥ 65 
(76’3) 
ND 1’8 
diseases 
Inability to, at least, one 
basic activity: 57% 
ND Mean: 3’6 
Drugs: 73’6% 
E1710 73’6% 60’1% - ND ND ND ND ND 
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female ≥81 
 
C: community     ND: Not described     LSI: long standing  institution 
In the overall analysis following IMU were important: 
Table 4.  Drug groups most commonly found 
DRUG GROUP Gravity according side effects 
probability 
n 
Anticholinergic-Antihistamines High 9 
Benzodiazepines High 10 
Tricyclicantidepressants High 10 
Antiplatelet Low 8 
Musclerelaxants High 6 
Antispasmodics High 8 
Digoxin Low 6 
Ferroussulphate Low 6 
Whichever version of Beers and studied scenario is agreement between the different studies that benzodiazepine (BDZ) are 
the drugs most identified as IMU.The long-acting BDZ should be avoided entirely in this population because of its effect of 
prolonged sedation, risk of falls and consequent fractures. Secondly, tricyclic antidepressants, antihistamines and 
anticholinergic also achieve high frequency as IMU and should be avoided due to their sedative and central nervous system 
depressants. 
Reviewing Beers 2012 includes this recommendation cited and classified as evidence IV and recommendation grade D. 
The 47.1% studies used Beers version 2003 (E11, E22, E36, E425, E618, E715, E821, E1219, and in Table 2). 
The measure of studies effect was the Odds ratio (n = 7; 41.2%). 
In most of the studies (n = 11; 64.7%) authors observed no association between the use of IMU and mortality.Only in 3 of 
them (E36, E1114, E1421, in Table 2) it was showed this association. 
Were included in the meta-analysis 8 items (E11, E36, E425, E523, E715, E821, E924, E1219 in Table 2) with a total of 90611 
participants aged.Here there was a statistically significant difference between elderly groups (p=0.022) regardless to 
mortality and a large heterogeneity of the studies (I2= 53.8 6%). 
Regarding the subgroup analysis, it was performed with 6 studies using Beers version 2003, with a total of 89164 users 
verifying anstatistical difference among elderly users of IMU for mortality risk (p=0.021) and with great heterogeneity 
(I2=62.09%). 
Subgroup analysis on the 3 studies conducted in hospitals (E425, E618, E1219, n=5530 elderly) demonstrated no statistical 
difference groups with mortality as a result (p=0.246) and moderate heterogeneity (I2 = 28.91%). 
Table 5 shows the synthesis of meta-analysis results including subgroup analysis. 
Table 5.  Summary of results of meta-analyses, including subgroup analyses. 
Outcome Number of 
studies 
Total 
patients 
Q (p) I2 
(IC 95%) 
overall 
estimate 
(IC 95%) 
p NNH Conclusion 
Mortality 
from all 
causes 
8 90611 15’17 
(0’033) 
53’86% (0 a 
79) 
1’11 (1’01 a 
1’22) 
0’022 36 Statistical 
difference 
Mortality 
versus Beers 
2003 
standard 
6 89164 13’18 62,09% 
(7 a 84) 
1,12 
(1,02 a 1,25) 
0’021 33 Statistical 
difference 
Mortality in 
the hospital 
3 5.530 2,81 
(0,244) 
28,91% 
(0 a 92) 
0,81 
(0,57 a 1,15) 
0’246 151 No statistical 
difference 
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4. Discussion 
This SR has found evidence to suggest that the elderly 
who used IMU had higher relative risk of death (RR=1.11, 
95% CI 1.01-1.22, p=0.023), according Beers criteria, 
regardless of the stage of study, comorbidities, 
polypharmacy or type of IMU used. 
In descriptive synthesis were included 1.6% of the total 
studies reviewed by title and abstract, results were quite 
similar to other RS that analysed the use of IMU (2%, 3%) 7, 
9, 20. 
This SR also found as general common characteristics to 
other studies the close relationship between aging and 
criteria development to assess the quality of care.Generally, 
these studies were conducted in developed countries, being 
USA the first to develop a criterion for classifying IMU. 
The study has been carried out predominantly from cohort 
studies, predominantly those of nature population and 
hospital environment held in long-stay institutions, with 
prospective data collection and non-probability 
sampling.Although it no represents the highest level of 
evidence, Phase IV studies whose data are obtained from 
databases are particularly relevant because the information 
has been obtained from actual conditions (heterogeneous 
population from various care settings and representative 
actual health services). 
The profile of the sample of elderly, found that female sex 
is prevalent in all studies of the SR, except one (E22, in Table 
2).This can be explained because older women tend to live 
longer than men, regardless of the stage and health 
conditions, older women are more likely to use IMU. 
This association of women and IMU may be due to 
biological matters (most exposed to health problems), 
psychological (worry more about their health / symptoms) 
and socio-cultural (most frequently used health services). 
In previous SR also showed that female gender is a risk 
factor associated with the use of IMU3, 4, 16, 17 
In all studies, age adopted the "elders" was in> 65 years, 
according to the WHO, except Brazil, which defined over 60 
years old as a person aged. 
In reference to the characteristics of the sample were 
found to age, number of diseases and medicines as well as 
the setting of care are variables that must be considered 
together because of their close relationship, because the 
older, larger number of diseases and drugs to treat.In 
addition there is usually an increase in hospitalizations 
number, and this population, are the ultimate users of 
long-stay facilities (nursing homes). 
The analysis reveals that the average age> 80 years and the 
average number of drugs consumed were higher for 
institutionalized elderly.These are generally more vulnerable 
to IMU use as other groups of elderly due to frailty and 
comorbidity present.Also showed that is a risk associated 
with the use of IMU in long-stay institutions have more than 
85 years and comorbidity (> 3 Charlson index). 
Moreover, the existence of multiple physicians 
prescribing carries an increased risk of polypharmacy, which 
in turn is set as a contributing factor to use of IMU.This is 
especially common in long-stay institutions which is 
corroborated by the evidence that SR has shown that the use 
of IMU is more pronounced among institutionalized elderly 
that in other healthcare settings. 
The fact that in some studies the authors did not clearly 
define the IMU concept (in terms of dose or therapy time) 
can be confusing, but always has been associated with older 
people. 
In the meta-analysis were included 8 studies reporting 
results with absolute frequency on sample and the results 
analysed, mortality.For this result was statistically 
significant difference (p = 0.02, 95% CI 1.01-1.22) between 
the two groups showing the harmful effects of the use of 
IMU for elderly as mortality outcome.This relationship, 
against the non-confirmation on the previous SR and refuted 
in other studies of the SR, is also found in three studies (E36, 
E1114, E1421, in Table 2) who obtained higher risk of death 
for the elderly in the IMU use. 
The studies heterogeneity was large (I2=53.86%) due to 
the differences in study scenarios (long-stay institutions 
(LSI), hospital and community, and community LSI), 
comorbidities users profile, number and class of drugs used 
as well as differences between drugs among countries. 
In the subgroup analysis (n=5530) in hospital setting, 
there was less heterogeneity of the studies (I2=28.91%) 
because users came from hospitals and drugs were classified 
according to 2003 Beers. 
The meta-analysis, provides no statistically significant 
difference between the groups, but showing a trend of lower 
mortality risk for elderly IMU users.This could be explained 
because in the hospital environment more patients are 
supervised by professionals on adverse drug effects and 
prescribing precautions IMU.However, more studies are 
needed to reinforce or refute these hypotheses given the 
weakness of the data. 
The use of random effect in this SR is justified by the 
studies diversity and heterogeneity.This model values small 
studies contribution providing a broader IC. 
NNH calculation for mortality from all causes was 36, i.e., 
for every 36 seniors who used IMU, one would die.In 
subgroup analysis yielded a similar result, NHH=33.By 
contrast, in subgroup analysis carried out with hospital 
studies was NHH = 151, which, in accordance with 
meta-analysis interpretation, we infer that the use of IMU in 
hospital setting protects the elderly of mortality outcome 
since each 151 IMU user, one perish. 
Drug therapy responds to the balance between the benefit 
and the harm a drug can bring.That is, the drug is prescribed 
looking for a positive effect of the same in order to try to 
improve individuals’ health because generally, without the 
drug, there’s not an improvement in health, sometimes even 
more damage.The problem arises in these patients with 
multiple disorders and visits to different specialists, each one 
prescribing in their health branch, may guide to incompatible 
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pharmacology situations and side effects, usually negative 
(morbidity and mortality).Thus the use of drugs requires an 
integrated interdisciplinary management and with the help of 
tool in health posed by the Beers criteria, Professionals can 
carry it out.The fact that an IMU-mortality relationship has 
been established, although not clearly evidenced yet, should 
encourage practitioners to treat pharmacologically with care 
on users and find strong results about it. 
5. Limitations 
This RS found limited to information availability from 
primary studies.The absence of responses to requests made 
to the authors of primary studies did not enable the inclusion 
of several studies in the meta-analysis, having been able to 
increase the sample to strengthen, with the possibility of 
showing a different result. 
Moreover, comorbidity, different drugs, and the type of 
facility or research context are a limitation by itself because 
heterogeneity that each of these variables can result. 
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